Facilitating Access to Approved Medication
Get Access To Sodium Phenylbutyrate And Taurursodiol For Oral Suspension
Sodium Phenylbutyrate And Taurursodiol For Oral Suspension
- API: sodium phenylbutyrate and taurursodiol
- Trade Name: On Request
- Packaging: oral suspension
- Strength: For oral suspension: 3 g sodium phenylbutyrate and 1 g taurursodiol in singledose packets.
- Indications:
What is Sodium Phenylbutyrate And Taurursodiol For Oral Suspension used for?
Sodium phenylbutyrate and Taurursodiolisis a fixed-dose combination medication used for the treatment of amyotrophic lateral sclerosis (ALS). It contains sodium phenylbutyrate and ursodoxicoltaurine (taurursodiol).The combination was approved for medical use in Canada as Albrioza, in June 2022, and in the United States, in September 2022.
Note: (For Prescribing Information Approved Drugs, see)
- The Food and Drug Administration (FDA), USA.
- The European Medicines Agency (EMA).
Disclaimer
All Trademarks and Brands that appear on website belong to their respective owners does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Sodium Phenylbutyrate And Taurursodiol For Oral Suspension is a pharmaceutical drug To access this medicine, a prescription of your treating doctor is necessary.. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.